Ross Muken, Chief Executive Officer at SOPHiA GENETICS, sold SOPH on Sep 21, 2026

Data as of Oct 16

▼ SELL$3.5K422 shares at $8.33Ross Muken Chief Executive OfficerSOPH SOPHiA GENETICS SA

Watch SOPH

Traded: Sep 21, 2026
Disclosed: Sep 22, 2026
Filed: 1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

SOPHSimilar stocks (S&P 500 (SPY)), rebased to SOPH's price on the disclosure day

SOPH since disclosure

−16.6%

after the sale

Similar stocks (SPY) since disclosure

−1.3%

S&P 500 (SPY)

Change in closing price from Sep 22, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

See every trade on SOPH →